Work

Supplemental Tables S1 and S2 from MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Table 1: MGD011 repeat-dose and dose-escalation study design in non-human primates; Supplemental Table 2: PK properties of MGD011 derived from non-human primate studies

DOI: 10.1158/1078-0432.22465025

Authors: Liqin Liu, Chia-Ying K. Lam, Vatana Long, Lusiana Widjaja, Yinhua Yang, Hua Li, Linda Jin, Steve Burke, Sergey Gorlatov, Jennifer Brown, Ralph Alderson, Margaret D. Lewis, Jeffrey L. Nordstrom, Scott Koenig, Paul A. Moore, Syd Johnson, Ezio Bonvini

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361925912

Cites:

Cited by:

Related to: 10